Publications by authors named "Luz Maria Fuenzalida"
Genomic and Phylogenomic Characterization of Carbapenem-resistant Pseudomonas aeruginosa 'High-risk' Clone O4/ExoS+/ST654 Circulating in Chilean Hospitals.
Andrés Opazo-Capurro Omar Alejandro Aguilar-Vera Paulina González-Muñoz Luis Amsteins-Romero Monserrat Quiroga Luz María Fuenzalida
J Glob Antimicrob Resist
September 2024
Article Synopsis
- Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is a major public health concern in Chile, mainly linked to ventilator-associated pneumonia, with limited molecular epidemiological data available.
- A study characterized the phylogenomics and molecular characteristics of ST654 CRPA isolates collected between 2016 and 2022, involving 89 samples from various hospitals.
- Results showed that 38.2% of the strains belonged to the high-risk ST654 clone, primarily associated with KPC production, a broad resistome, and specific virulence factors, highlighting the need for ongoing molecular surveillance.
[Recommendations for the study and pharmacological management in adult patients with suspected infection by SARS-CoV-2 (COVID-19)].
Jorge Pérez Godoy Ruth Rosales Chacón Fernando Bernal Ortiz Cecilia Luengo Messen José Miguel Arancibia Henríquez Luz María Fuenzalida
Rev Chilena Infectol
December 2020
[First isolation de Candida auris in Chile].
María Victoria Moreno María Elvira Simian Javier Villarroel Luz María Fuenzalida María Fernanda Yarad
Rev Chilena Infectol
December 2019
Candida auris is an emerging multi-drug-resistant fungus that is rapidly spreading worldwide. Since the first reports in 2009, many isolates across five continents have been identified as agents of hospital-associated infections. Independent and simultaneous outbreaks of C.
View Article and Find Full Text PDF